PTGX icon

Protagonist Therapeutics
PTGX

Overview Fund Activity

136 hedge funds and large institutions have $522M invested in Protagonist Therapeutics in 2022 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 51 increasing their positions, 42 reducing their positions, and 15 closing their positions.

Holders
136
Holders Change
+7
Holders Change %
+5.43%
% of All Funds
2.19%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
23
Increased
51
Reduced
42
Closed
15
Calls
$10.4M
Puts
$2.59M
Net Calls
+$7.79M
Net Calls Change
+$1.64M

Top Buyers

1
Citadel Advisors
1
Citadel Advisors
Florida
$25.7M
2
Millennium Management
2
Millennium Management
New York
$14.7M
3
DTC
3
Deep Track Capital
Connecticut
$9.51M
4
Marshall Wace
4
Marshall Wace
United Kingdom
$15.9M
5
WP
5
Woodline Partners
California
$5.59M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$748K
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$3.45M
3
State Street
3
State Street
Massachusetts
$41.4M
4
RI
4
RTW Investments
New York
$39.2M
5
Voloridge Investment Management
5
Voloridge Investment Management
Florida
$1.83M
Name Holding Trade Value Shares
Change 		Shares
Change %
Nuveen Asset Management
26
Nuveen Asset Management
Illinois
$3.94M +$242K +22,170 +7%
KCM
27
Kennedy Capital Management
Missouri
$3.82M +$2.74M +251,046 +253%
Bank of America
28
Bank of America
North Carolina
$3.76M +$381K +34,898 +11%
Charles Schwab
29
Charles Schwab
California
$3.71M +$69.6K +6,378 +2%
Point72 Asset Management
30
Point72 Asset Management
Connecticut
$3.45M -$24.2M -2,221,493 -88%
JPMorgan Chase & Co
31
JPMorgan Chase & Co
New York
$3.31M +$1.39M +127,603 +73%
Rafferty Asset Management
32
Rafferty Asset Management
New York
$3.22M -$563K -51,587 -15%
Jacobs Levy Equity Management
33
Jacobs Levy Equity Management
New Jersey
$3.1M +$325K +29,775 +12%
Renaissance Technologies
34
Renaissance Technologies
New York
$2.82M -$1.54M -140,900 -35%
Barclays
35
Barclays
United Kingdom
$2.78M +$424K +38,893 +18%
SAM
36
Silvercrest Asset Management
New York
$2.63M -$24.7K -2,268 -0.9%
SCM
37
Soleus Capital Management
Connecticut
$2.57M +$2.57M +236,000 New
UBS Group
38
UBS Group
Switzerland
$2.46M +$1.95M +178,949 +384%
GC
39
Gratus Capital
Georgia
$2.39M +$141K +12,946 +6%
6CM
40
683 Capital Management
New York
$2.27M +$2.27M +207,800 New
Russell Investments Group
41
Russell Investments Group
United Kingdom
$2.17M -$348K -31,878 -14%
Connor, Clark & Lunn Investment Management (CC&L)
42
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$2.12M +$38.3K +3,511 +2%
D.E. Shaw & Co
43
D.E. Shaw & Co
New York
$2.05M +$491K +44,961 +31%
Voloridge Investment Management
44
Voloridge Investment Management
Florida
$1.83M -$2.83M -259,024 -61%
Bank of New York Mellon
45
Bank of New York Mellon
New York
$1.79M +$68.4K +6,266 +4%
RCAMU
46
Rothschild & Co Asset Management US
Connecticut
$1.67M -$13K -1,188 -0.8%
Norges Bank
47
Norges Bank
Norway
$1.62M +$1.62M +148,700 New
Citigroup
48
Citigroup
New York
$1.62M -$1.82M -167,126 -53%
VOYA Investment Management
49
VOYA Investment Management
Georgia
$1.52M -$77K -7,060 -5%
Qube Research & Technologies (QRT)
50
Qube Research & Technologies (QRT)
United Kingdom
$1.48M +$485K +44,430 +49%
1
2
3 4 5